The therapeutic efficacy of glipizide can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of cisplatin can be decreased when used in combination with lipoic acid.


The therapeutic efficacy of Ulipristal can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of Miglustat can be decreased when used in combination with piperazine.


The therapeutic efficacy of liothyronine can be decreased when used in combination with nefazodone.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with piperazine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with alclofenac.


The therapeutic efficacy of nateglinide can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with CEFORANIDE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of procyclidine can be decreased when used in combination with donepezil.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Octreotide.


The therapeutic efficacy of warfarin can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with diflorasone.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of betahistine can be decreased when used in combination with ranitidine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with goserelin.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of folic acid can be decreased when used in combination with alclofenac.


The therapeutic efficacy of Travoprost can be decreased when used in combination with suprofen.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with quetiapine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with celecoxib.


The therapeutic efficacy of liothyronine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of norgestrel can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with floctafenine.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with floctafenine.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of Limaprost can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of liothyronine can be decreased when used in combination with sertraline.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with etodolac.


The therapeutic efficacy of Apixaban can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of glyburide can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of acarbose can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of tolterodine can be decreased when used in combination with donepezil.


The therapeutic efficacy of Penicillin G benzathine can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of dicumarol can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with suprofen.


The therapeutic efficacy of SULBACTAM can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Retigabine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with betamethasone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with suprofen.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of estramustine can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of etizolam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Miglustat can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of metolazone can be decreased when used in combination with epirizole.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of gemeprost can be decreased when used in combination with chloroquine.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with VALPROIC ACID.


The therapeutic efficacy of Thioproperazine can be decreased when used in combination with pramipexole.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with pentamidine.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with thiamylal.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with decamethonium.


The therapeutic efficacy of Travoprost can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with nimesulide.


The therapeutic efficacy of polythiazide can be decreased when used in combination with nimesulide.


The therapeutic efficacy of Tiludronic Acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with bumetanide.


The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with acemetacin.


The therapeutic efficacy of acarbose can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Salsalate.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of indapamide can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of levodopa can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of metolazone can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of PIPECURONIUM can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of glyburide can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of misoprostol can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of temazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of 11C-choline chloride can be decreased when used in combination with bicalutamide.


The therapeutic efficacy of tolazamide can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with norethindrone.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with etodolac.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cephradine.


The therapeutic efficacy of perphenazine can be decreased when used in combination with amantadine.


The therapeutic efficacy of betahistine can be decreased when used in combination with chlorpheniramine.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Octreotide.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Fosamprenavir.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with mefloquine.


The therapeutic efficacy of metolazone can be decreased when used in combination with leflunomide.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of tolazamide can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of clonazepam can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with amphotericin b.


The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of betahistine can be decreased when used in combination with promethazine.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with metronidazole.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Atomoxetine.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Travoprost can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with ondansetron.


The therapeutic efficacy of voglibose can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with allylestrenol.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with carprofen.


The therapeutic efficacy of Mometasone can be decreased when used in combination with amoxapine.


The therapeutic efficacy of glyburide can be decreased when used in combination with betamethasone.


The therapeutic efficacy of betahistine can be decreased when used in combination with DIMENHYDRINATE.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with donepezil.


The therapeutic efficacy of anastrozole can be decreased when used in combination with tibolone.


The therapeutic efficacy of PIPECURONIUM can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of Vecuronium can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of pancuronium can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of metformin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of liothyronine can be decreased when used in combination with mestranol.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of metformin can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of voglibose can be decreased when used in combination with Torasemide.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Torasemide.


The therapeutic efficacy of Gestrinone can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of acemetacin can be decreased when used in combination with levonordefrin.


The therapeutic efficacy of calcitriol can be decreased when used in combination with flurandrenolide.


The therapeutic efficacy of ipratropium can be decreased when used in combination with mefloquine.


The therapeutic efficacy of MAGNESIUM SULFATE can be decreased when used in combination with mefloquine.


The therapeutic efficacy of apomorphine can be decreased when used in combination with olanzapine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of gliclazide can be decreased when used in combination with danazol.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with danazol.


The therapeutic efficacy of Miglustat can be decreased when used in combination with mestranol.


The therapeutic efficacy of metformin can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Penicillin G benzathine.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with ambenonium.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of estramustine can be decreased when used in combination with secobarbital.


The therapeutic efficacy of betaxolol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of codeine can be decreased when used in combination with Quinine.


The therapeutic efficacy of EXEMESTANE can be decreased when used in combination with diethylstilbestrol.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Asenapine.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with sulindac.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Abiraterone can be decreased when used in combination with spironolactone.


The therapeutic efficacy of ACENOCOUMAROL can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of metolazone can be decreased when used in combination with celecoxib.


The therapeutic efficacy of desoximetasone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of citric acid can be decreased when used in combination with norethindrone.


The therapeutic efficacy of voglibose can be decreased when used in combination with estradiol.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of acarbose can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Dienogest.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with SAQUINAVIR.


The therapeutic efficacy of Limaprost can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with CLOCORTOLONE.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with terbinafine.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with Benidipine.


The therapeutic efficacy of ACENOCOUMAROL can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with PERHEXILINE.


The therapeutic efficacy of calcitriol can be decreased when used in combination with Fluprednidene.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with piperazine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with tolmetin.


The therapeutic efficacy of alprostadil can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Eplerenone can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with naltrexone.


The therapeutic efficacy of Dienogest can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of mesalamine can be decreased when used in combination with Aluminium.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Bethanidine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with tolmetin.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of mesalamine can be decreased when used in combination with epinastine.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of calcitriol can be decreased when used in combination with paramethasone.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with danazol.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with felodipine.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with nimesulide.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of glipizide can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with methoxamine.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Torasemide.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with clozapine.


The therapeutic efficacy of estramustine can be decreased when used in combination with tretinoin.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with phenmetrazine.


The therapeutic efficacy of acarbose can be decreased when used in combination with Asenapine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Fusafungine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with floctafenine.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with fenbufen.


The therapeutic efficacy of glyburide can be decreased when used in combination with progesterone.


The therapeutic efficacy of Perampanel can be decreased when used in combination with mianserin.


The therapeutic efficacy of nafcillin can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of calcitriol can be decreased when used in combination with alclometasone.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Dienogest.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of biperiden can be decreased when used in combination with edrophonium.


The therapeutic efficacy of indapamide can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of acetazolamide can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of tropicamide can be decreased when used in combination with edrophonium.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with ranitidine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of pyridostigmine can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of biperiden can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with amprenavir.


The therapeutic efficacy of scopolamine can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of glimepiride can be decreased when used in combination with nelfinavir.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of diflorasone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of liothyronine can be decreased when used in combination with Levomilnacipran.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with RIMEXOLONE.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of ACENOCOUMAROL can be decreased when used in combination with allylestrenol.


The therapeutic efficacy of ANISOTROPINE METHYLBROMIDE can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with manidipine.


The therapeutic efficacy of EDTA can be decreased when used in combination with norethindrone.


The therapeutic efficacy of nimesulide can be decreased when used in combination with calcium lactate.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with formestane.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with tolmetin.


The therapeutic efficacy of Desloratadine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of betahistine can be decreased when used in combination with Alcaftadine.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with fluocinonide.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with floctafenine.


The therapeutic efficacy of nitrazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of 11C-choline chloride can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of latanoprost can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with norethindrone.


The therapeutic efficacy of prochlorperazine can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of cinnarizine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of metformin can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of gliclazide can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with Escitalopram.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of flumazenil can be decreased when used in combination with aminophylline.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with memantine.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of acarbose can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Dirithromycin.


The therapeutic efficacy of nimodipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with diclofenac.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of glipizide can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of voglibose can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of alprostadil can be decreased when used in combination with celecoxib.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with celecoxib.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cephapirin.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Spectinomycin.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of polythiazide can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of Olmesartan can be decreased when used in combination with acemetacin.


The therapeutic efficacy of isradipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of temazepam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with salicylamide.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of glipizide can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of Bortezomib can be decreased when used in combination with l-ascorbic acid.


The therapeutic efficacy of Ximelagatran can be decreased when used in combination with allylestrenol.


The therapeutic efficacy of trifluoperazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with indomethacin.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with sulindac.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Enalaprilat.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of gemeprost can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of periciazine can be decreased when used in combination with pramipexole.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with amoxicillin.


The therapeutic efficacy of Lercanidipine can be decreased when used in combination with calcium lactate.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with thiamylal.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with histrelin.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Radioiodine can be decreased when used in combination with propylthiouracil.


The therapeutic efficacy of folic acid can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of latanoprost can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ribostamycin.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with indomethacin.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with mesalamine.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with FLUOCINOLONE ACETONIDE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with risperidone.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Dienogest.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Salsalate.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Dienogest.


The therapeutic efficacy of nateglinide can be decreased when used in combination with bumetanide.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of latanoprost can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with etodolac.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with goserelin.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with metolazone.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with Tixocortol.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with alclofenac.


The therapeutic efficacy of acemetacin can be decreased when used in combination with Oxilofrine.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with DEFLAZACORT.


The therapeutic efficacy of nimesulide can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with sertraline.


The therapeutic efficacy of estradiol can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Oritavancin.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of stavudine can be decreased when used in combination with zidovudine.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with prednisone.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Salsalate.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Acitretin.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Salsalate.


The therapeutic efficacy of SULBACTAM can be decreased when used in combination with doxycycline.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with doxycycline.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Penicillin G benzathine can be decreased when used in combination with doxycycline.


The therapeutic efficacy of warfarin can be decreased when used in combination with progesterone.


The therapeutic efficacy of Travoprost can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with progesterone.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with aspirin.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of ZILEUTON can be decreased when used in combination with amoxapine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with NATAMYCIN.


The therapeutic efficacy of metformin can be decreased when used in combination with piperazine.


The therapeutic efficacy of piperacillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Travoprost can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with novobiocin.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Miglustat can be decreased when used in combination with epinephrine.


The therapeutic efficacy of chlorprothixene can be decreased when used in combination with levodopa.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with epinephrine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with donepezil.


The therapeutic efficacy of phenindione can be decreased when used in combination with norethindrone.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of gemeprost can be decreased when used in combination with Droxicam.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with etodolac.


The therapeutic efficacy of metolazone can be decreased when used in combination with aspirin.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Droxicam.


The therapeutic efficacy of voglibose can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of Pipamperone can be decreased when used in combination with Quinagolide.


The therapeutic efficacy of gliclazide can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of Miglustat can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of folic acid can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with Milnacipran.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with chloroxine.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Salsalate.


The therapeutic efficacy of bisacodyl can be decreased when used in combination with Almasilate.


The therapeutic efficacy of probenecid can be decreased when used in combination with aspirin.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with Lacidipine.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Demecarium.


The therapeutic efficacy of latanoprost can be decreased when used in combination with suprofen.


The therapeutic efficacy of Limaprost can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Miglustat can be decreased when used in combination with progesterone.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with malathion.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with floctafenine.


The therapeutic efficacy of calcitriol can be decreased when used in combination with difluprednate.


The therapeutic efficacy of bisacodyl can be decreased when used in combination with SODIUM BICARBONATE.


The therapeutic efficacy of chenodeoxycholic acid can be decreased when used in combination with clofibrate.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with Fluprednidene.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with sparfloxacin.


The therapeutic efficacy of Ibandronic Acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of Ifenprodil can be decreased when used in combination with mianserin.


The therapeutic efficacy of Tramadol can be decreased when used in combination with isoniazid.


The therapeutic efficacy of HEROIN can be decreased when used in combination with naltrexone.


The therapeutic efficacy of apomorphine can be decreased when used in combination with Blonanserin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with diclofenac.


The therapeutic efficacy of EDTA can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of codeine can be decreased when used in combination with tranylcypromine.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with furosemide.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with fluocinonide.


The therapeutic efficacy of glyburide can be decreased when used in combination with Torasemide.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with diflorasone.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of gliclazide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of ipratropium can be decreased when used in combination with malathion.


The therapeutic efficacy of riluzole can be decreased when used in combination with mianserin.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of Pregabalin can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with paramethasone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of thiothixene can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of Thioproperazine can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of Zuclopenthixol can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of PARALDEHYDE can be decreased when used in combination with mianserin.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of Eslicarbazepine acetate can be decreased when used in combination with mianserin.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with alclometasone.


The therapeutic efficacy of oxprenolol can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of KETAZOLAM can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of prazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Etomidate can be decreased when used in combination with mianserin.


The therapeutic efficacy of ethosuximide can be decreased when used in combination with METHAMPHETAMINE.


The therapeutic efficacy of Miglustat can be decreased when used in combination with pentamidine.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with epirizole.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with pentamidine.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Droxicam.


The therapeutic efficacy of lorazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with Clobetasone.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefotetan.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Asenapine.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of folic acid can be decreased when used in combination with carprofen.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with rapamycin.


The therapeutic efficacy of indapamide can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with thiopental.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Pipotiazine.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Tianeptine.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of codeine can be decreased when used in combination with cimetidine.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of voglibose can be decreased when used in combination with prednisone.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Icatibant.


The therapeutic efficacy of tolazamide can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Progabide can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of citric acid can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of Phensuximide can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of cloxacillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with metolazone.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of Cyamemazine can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of ursodiol can be decreased when used in combination with bezafibrate.


The therapeutic efficacy of estramustine can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with memantine.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with nelfinavir.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of flunarizine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with doxepin.


The therapeutic efficacy of glipizide can be decreased when used in combination with Asenapine.


The therapeutic efficacy of metolazone can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with dydrogesterone.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with fenbufen.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Aceprometazine.


The therapeutic efficacy of nilvadipine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with ketorolac.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with flunarizine.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with leflunomide.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with physostigmine.


The therapeutic efficacy of fludiazepam can be decreased when used in combination with mefloquine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with leflunomide.


The therapeutic efficacy of xylometazoline can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of tropicamide can be decreased when used in combination with physostigmine.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of glipizide can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of metformin can be decreased when used in combination with Articaine.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with decamethonium.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of acemetacin can be decreased when used in combination with PROCATEROL.


The therapeutic efficacy of Conivaptan can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Eprosartan can be decreased when used in combination with acemetacin.


The therapeutic efficacy of voglibose can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with celecoxib.


The therapeutic efficacy of latanoprost can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Travoprost can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Dienogest can be decreased when used in combination with Acitretin.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of tizanidine can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of manidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Delorazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of Azelnidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Benidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Lacidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Efonidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of amisulpride can be decreased when used in combination with levodopa.


The therapeutic efficacy of flumazenil can be decreased when used in combination with theophylline.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of tolterodine can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of glimepiride can be decreased when used in combination with norethindrone.


The therapeutic efficacy of metformin can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of glipizide can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of metformin can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of Propiverine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of acarbose can be decreased when used in combination with Pipotiazine.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with periciazine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with metolazone.


The therapeutic efficacy of clonazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with epinephrine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of amantadine can be decreased when used in combination with olanzapine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with sulindac.


The therapeutic efficacy of latanoprost can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of glipizide can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of tropicamide can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with terbutaline.


The therapeutic efficacy of fludiazepam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with SAQUINAVIR.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with CLOBETASOL PROPIONATE.


The therapeutic efficacy of Lacidipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with ritonavir.


The therapeutic efficacy of manidipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with sulfacetamide.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with droxidopa.


The therapeutic efficacy of promazine can be decreased when used in combination with levodopa.


The therapeutic efficacy of midazolam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of Metixene can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of procyclidine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with clarithromycin.


The therapeutic efficacy of nicardipine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of allylestrenol can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with diazoxide.


The therapeutic efficacy of Miglustat can be decreased when used in combination with diazoxide.


The therapeutic efficacy of misoprostol can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with prochlorperazine.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with fenbufen.


The therapeutic efficacy of polythiazide can be decreased when used in combination with fenbufen.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with flurandrenolide.


The therapeutic efficacy of MOXONIDINE can be decreased when used in combination with cyclobenzaprine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with sulindac.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Lopinavir.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with bumetanide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of chenodeoxycholic acid can be decreased when used in combination with diethylstilbestrol.


The therapeutic efficacy of acarbose can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of flunarizine can be decreased when used in combination with mianserin.


The therapeutic efficacy of quinidine can be decreased when used in combination with spironolactone.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Perospirone.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with Lymecycline.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with prednisone.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with Acitretin.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of glimepiride can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with betamethasone.


The therapeutic efficacy of metformin can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of polythiazide can be decreased when used in combination with diflunisal.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with diflunisal.


The therapeutic efficacy of Tramadol can be decreased when used in combination with clemastine.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with isradipine.


The therapeutic efficacy of misoprostol can be decreased when used in combination with epirizole.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with alclofenac.


The therapeutic efficacy of dicloxacillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with budesonide.


The therapeutic efficacy of phenobarbital can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Ciclesonide can be decreased when used in combination with amoxapine.


The therapeutic efficacy of betahistine can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with celecoxib.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with FLUOCINOLONE ACETONIDE.


The therapeutic efficacy of tolazamide can be decreased when used in combination with indinavir.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of meprobamate can be decreased when used in combination with mefloquine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with leflunomide.


The therapeutic efficacy of ETONOGESTREL can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of tropicamide can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Etomidate.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Acitretin.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of Liotrix can be decreased when used in combination with nefazodone.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with DEFLAZACORT.


The therapeutic efficacy of glimepiride can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of calcitriol can be decreased when used in combination with Fluticasone furoate.


The therapeutic efficacy of betahistine can be decreased when used in combination with diphenhydramine.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with BECLOMETHASONE DIPROPIONATE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of glimepiride can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of acemetacin can be decreased when used in combination with Carbamylcholine.


The therapeutic efficacy of Nitroprusside can be decreased when used in combination with acemetacin.


The therapeutic efficacy of apomorphine can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of nimodipine can be decreased when used in combination with calcium lactate.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Trospium can be decreased when used in combination with donepezil.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with nafcillin.


The therapeutic efficacy of acarbose can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with ROXATIDINE ACETATE.


The therapeutic efficacy of ACENOCOUMAROL can be decreased when used in combination with dydrogesterone.


The therapeutic efficacy of Propiverine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of indapamide can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of latanoprost can be decreased when used in combination with indomethacin.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of scopolamine can be decreased when used in combination with malathion.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with resveratrol.


The therapeutic efficacy of codeine can be decreased when used in combination with sertraline.


The therapeutic efficacy of Limaprost can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with nabumetone.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Torasemide.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Fidaxomicin.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with DESONIDE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with amoxapine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with ropinirole.


The therapeutic efficacy of acarbose can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with tretinoin.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with diclofenac.


The therapeutic efficacy of MOLINDONE can be decreased when used in combination with levodopa.


The therapeutic efficacy of cinnarizine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of polythiazide can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with CLOCORTOLONE.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with desoximetasone.


The therapeutic efficacy of ethosuximide can be decreased when used in combination with Lisdexamfetamine.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with danazol.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with aspirin.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Ertapenem.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Icatibant.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of Miglustat can be decreased when used in combination with ceritinib.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with salicylamide.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with terconazole.


The therapeutic efficacy of indapamide can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of loxapine can be decreased when used in combination with amantadine.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Darunavir.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Lopinavir.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of Penicillin G benzathine can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of SULBACTAM can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of mesalamine can be decreased when used in combination with Asenapine.


The therapeutic efficacy of levodopa can be decreased when used in combination with phenytoin.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with furosemide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Articaine.


The therapeutic efficacy of codeine can be decreased when used in combination with Mirabegron.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with bumetanide.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with tioconazole.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of chlordiazepoxide can be decreased when used in combination with aminophylline.


The therapeutic efficacy of indapamide can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of glimepiride can be decreased when used in combination with betamethasone.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with TROLEANDOMYCIN.


The therapeutic efficacy of mestranol can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of metolazone can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of acarbose can be decreased when used in combination with quetiapine.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of metformin can be decreased when used in combination with epinephrine.


The therapeutic efficacy of CYPROTERONE ACETATE can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Articaine.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with mestranol.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with goserelin.


The therapeutic efficacy of oxazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Apremilast.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Miglustat can be decreased when used in combination with prednisone.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with prednisone.


The therapeutic efficacy of dobutamine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with epinastine.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Asenapine.


The therapeutic efficacy of duloxetine can be decreased when used in combination with CYPROHEPTADINE.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Gramicidin D.


The therapeutic efficacy of theobromine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of apraclonidine can be decreased when used in combination with mianserin.


The therapeutic efficacy of zaleplon can be decreased when used in combination with mianserin.


The therapeutic efficacy of METHSUXIMIDE can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of voglibose can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with aspirin.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with edrophonium.


The therapeutic efficacy of indapamide can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of nateglinide can be decreased when used in combination with danazol.


The therapeutic efficacy of mesalamine can be decreased when used in combination with omeprazole.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with SERTINDOLE.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of Travoprost can be decreased when used in combination with etodolac.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of loxapine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with doxepin.


The therapeutic efficacy of EXEMESTANE can be decreased when used in combination with tibolone.


The therapeutic efficacy of mifepristone can be decreased when used in combination with DEXKETOPROFEN.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with eperisone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with donepezil.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with mestranol.


The therapeutic efficacy of Liotrix can be decreased when used in combination with diethylstilbestrol.


The therapeutic efficacy of glipizide can be decreased when used in combination with risperidone.


The therapeutic efficacy of ursodiol can be decreased when used in combination with Fenofibric acid.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of nafcillin can be decreased when used in combination with minocycline.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with aspirin.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with paroxetine.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of Risedronic acid can be decreased when used in combination with rabeprazole.


The therapeutic efficacy of glipizide can be decreased when used in combination with ritonavir.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with ritonavir.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with Lopinavir.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Lopinavir.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of nicardipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of cinnarizine can be decreased when used in combination with calcium lactate.


The therapeutic efficacy of clorazepate can be decreased when used in combination with dyphylline.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of Limaprost can be decreased when used in combination with acemetacin.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of Ibandronic Acid can be decreased when used in combination with dexlansoprazole.


The therapeutic efficacy of loxapine can be decreased when used in combination with levodopa.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of calcitriol can be decreased when used in combination with PREDNICARBATE.


The therapeutic efficacy of voglibose can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with polythiazide.


The therapeutic efficacy of glyburide can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of glimepiride can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of tibolone can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Travoprost can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of propantheline can be decreased when used in combination with memantine.


The therapeutic efficacy of mestranol can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with FLUOCORTOLONE.


The therapeutic efficacy of latanoprost can be decreased when used in combination with tolmetin.


The therapeutic efficacy of indapamide can be decreased when used in combination with azelastine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of malathion can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with goserelin.


The therapeutic efficacy of ALENDRONIC ACID can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of mestranol can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with RIMEXOLONE.


The therapeutic efficacy of glipizide can be decreased when used in combination with furosemide.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with thiopental.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of metformin can be decreased when used in combination with furosemide.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with MAGNESIUM SULFATE.


The therapeutic efficacy of acarbose can be decreased when used in combination with Fosamprenavir.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with flunisolide.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of glimepiride can be decreased when used in combination with SAQUINAVIR.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of piperacillin can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of codeine can be decreased when used in combination with Lorcaserin.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of voglibose can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of voglibose can be decreased when used in combination with progesterone.


The therapeutic efficacy of folic acid can be decreased when used in combination with mesalamine.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with epirizole.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with metolazone.


The therapeutic efficacy of glyburide can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with indomethacin.


The therapeutic efficacy of codeine can be decreased when used in combination with diphenhydramine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ceftibuten.


The therapeutic efficacy of tolterodine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of nilvadipine can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of felodipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of codeine can be decreased when used in combination with clemastine.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with Tixocortol.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with BECLOMETHASONE DIPROPIONATE.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of glipizide can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of diazepam can be decreased when used in combination with mefloquine.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with quetiapine.


The therapeutic efficacy of acemetacin can be decreased when used in combination with formoterol.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with edrophonium.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of 11C-choline chloride can be decreased when used in combination with histrelin.


The therapeutic efficacy of liothyronine can be decreased when used in combination with venlafaxine.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of polythiazide can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of spironolactone can be decreased when used in combination with acemetacin.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of meperidine can be decreased when used in combination with naltrexone.


The therapeutic efficacy of levonordefrin can be decreased when used in combination with mianserin.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with thiamylal.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with quetiapine.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of doxorubicin can be decreased when used in combination with Dexrazoxane.


The therapeutic efficacy of xylometazoline can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of acemetacin can be decreased when used in combination with Miltefosine.


The therapeutic efficacy of nateglinide can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with desoximetasone.


The therapeutic efficacy of ANISOTROPINE METHYLBROMIDE can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of acarbose can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of Lormetazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with Tavaborole.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with acemetacin.


The therapeutic efficacy of DESERPIDINE can be decreased when used in combination with acemetacin.


The therapeutic efficacy of alprostadil can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of flunarizine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with tretinoin.


The therapeutic efficacy of propantheline can be decreased when used in combination with decamethonium.


The therapeutic efficacy of metformin can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with alclofenac.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with nabumetone.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Apremilast.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of betahistine can be decreased when used in combination with azelastine.


The therapeutic efficacy of acarbose can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of calcitriol can be decreased when used in combination with amcinonide.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with azlocillin.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with histrelin.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with histrelin.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with MELPERONE.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with primidone.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with difluprednate.


The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with donepezil.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with malathion.


The therapeutic efficacy of gliclazide can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of ARBUTAMINE can be decreased when used in combination with betahistine.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of metformin can be decreased when used in combination with diazoxide.


The therapeutic efficacy of alprostadil can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of temazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Pregabalin can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of PAMIDRONIC ACID can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of flunitrazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of ethyl loflazepate can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with progesterone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with ritonavir.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with salicylamide.


The therapeutic efficacy of glyburide can be decreased when used in combination with Articaine.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with ritonavir.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with nimesulide.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with fenbufen.


The therapeutic efficacy of promazine can be decreased when used in combination with amantadine.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with diflunisal.